← Leaderboards
Aras Nikodemas Mattis
University Of California, San Francisco
$4,766,021
Attributed
$9,063,818
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,063,818 · 4
By mechanism
RC2$4,780,391 · 1
R01$3,494,643 · 2
K08$788,784 · 1
Top collaborators
- Marisa Wong Medina4 shared
- Jacquelyn J. Maher3 shared
- Holger Willenbring3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Laura Fejerman$6,376,255
- Martin Valdearcos$1,898,370
- Stephen J. Dearmond$6,907,203
- Jinoos Yazdany$14,867,893
- William Reid Bolus$231,718
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeHepatocyteLiver DiseasesGenesLiverLipidsGeneticHepaticNonalcoholic SteatohepatitisAffectInsulin ResistanceCirrhosisFibrosisResearch Project GrantsHypertriglyceridemiaAmericanInduced Pluripotent Stem CellFatty Acid Glycerol EstersDisease ModelBiologyDisease PhenotypeLipid MetabolismAdultCell Line
Grant awards (15)
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD$1,614,997
RC2 · FY2025 · DK
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family$602,955
R01 · FY2025 · DK · contact PI
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD$1,550,397
RC2 · FY2024 · DK
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family$669,949
R01 · FY2024 · DK · contact PI
Genetic Regulation of Nonalcoholic Fatty Liver Disease$537,831
R01 · FY2024 · DK
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD$1,614,997
RC2 · FY2023 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease$560,240
R01 · FY2023 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease$564,108
R01 · FY2022 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease$559,560
R01 · FY2021 · DK
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$171,900
K08 · FY2017 · DK · contact PI
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$153,846
K08 · FY2016 · DK · contact PI
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$153,846
K08 · FY2015 · DK · contact PI
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$1,500
K08 · FY2015 · DK · contact PI
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$153,846
K08 · FY2014 · DK · contact PI
Regulation of Lipid Metabolism by miR-29a within Hepatocytes$153,846
K08 · FY2013 · DK · contact PI